ACE2 and COVID-19: Hence, AA-ACE2 (by reducing the activity of transmembrane ACE2 and transformation of Ang II to Ang 1-7) increased the activity of AT1 receptor, enhanced pro-inflammatory response, and ACE2 shedding (94, 95), thereby aggravating the severity of COVID-19.